Kazazian Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-4,392
Closed -$57K 87
2015
Q3
$57K Buy
4,392
+350
+9% +$4.54K 0.07% 76
2015
Q2
$88K Buy
+4,042
New +$88K 0.09% 64